Product NDC: | 0409-0201 |
Proprietary Name: | Docetaxel |
Non Proprietary Name: | DOCETAXEL ANHYDROUS |
Active Ingredient(s): | 10 mg/mL & nbsp; DOCETAXEL ANHYDROUS |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-0201 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022234 |
Marketing Category: | NDA |
Start Marketing Date: | 20110308 |
Package NDC: | 0409-0201-20 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-0201-20) > 16 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0409-0201-20 |
Proprietary Name | Docetaxel |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-0201-20) > 16 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0409-0201 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DOCETAXEL ANHYDROUS |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110308 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | DOCETAXEL ANHYDROUS |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |